Malignant neoplasm of left ureter
ICD-10 C66.2 is a billable code used to indicate a diagnosis of malignant neoplasm of left ureter.
C66.2 refers to a malignant neoplasm located in the left ureter, which is a critical component of the urinary tract responsible for transporting urine from the kidneys to the bladder. Malignant neoplasms of the ureter are relatively rare compared to other urinary tract malignancies, such as bladder cancer or renal cell carcinoma. The clinical presentation may include hematuria (blood in urine), flank pain, and urinary obstruction. Diagnosis typically involves imaging studies such as CT scans, MRI, or ultrasound, along with cystoscopy and biopsy for histological confirmation. Staging of ureteral cancer is crucial for determining the appropriate treatment approach, which may include surgical resection, chemotherapy, or radiation therapy. Surgical management often involves nephroureterectomy, where the affected ureter and potentially the kidney are removed, especially in cases of localized disease. The prognosis depends on the stage at diagnosis, with early-stage cancers having a better outcome than those diagnosed at a more advanced stage.
Detailed operative reports, imaging studies, and pathology results are essential for accurate coding.
Urologists frequently encounter patients with hematuria, flank pain, or urinary obstruction due to ureteral malignancies.
Urologists must ensure that all relevant findings are documented, including tumor size, location, and any associated renal involvement.
Comprehensive cancer staging documentation, including imaging and biopsy results.
Oncologists often manage patients post-surgery or those undergoing chemotherapy for ureteral cancer.
Oncologists should document treatment plans and responses to therapy to support coding for malignancy.
Used for surgical management of malignant neoplasm of the ureter.
Operative report detailing the procedure and findings.
Urologists must document the extent of resection and any complications.
The primary treatment is often surgical resection, typically nephroureterectomy, depending on the stage and extent of the disease.
